Sunday, August 10, 2025 3:29:44 PM
zero82,
“I hear..” 😶 Source, please?
Thanks for reposting your free psychic predictions, but it sounds like you’re just spreading baseless rumors.
I thought you advised us to stick to “only hard facts” 😶 ..and we are much more interested in reliable sources & FACTS.
Examples of Reliable Sources:
☑️ Regulatory Agencies
☑️ U.S. DoD Grant Peer Reviewers
☑️ U.S. NIH Grant Peer Reviewers
☑️ Independently Peer-Reviewed Medical Journals
☑️ UCLA Jonsson Comprehensive Cancer Center
(NCI-Designated Cancer Center)
☑️ University of Pittsburgh Hillman Cancer Center
(NCI-Designated Cancer Center)
☑️ Roswell Park Comprehensive Cancer Institute
(NCI-Designated Cancer Center)
“Later this fall,” we want to see further updates & interim data on clinical trials. PII is a key stage for combo studies. New or expanded trials may soon be underway depending on funding & new partnerships or expansion of existing collaborations…
For example, we’re all interested in factual developments related to this PII Combo Trial at Roswell Park —
✅️ recently updated on clinicaltrials.gov
✅️ recently published/promoted at ASCO
✅️ recently expanded in scope
✅️ supported by a competitive peer-reviewed grant awarded by the U.S. DoD
✅️ includes Merck’s pembrolizumab
✅️ has a trial site at Moffitt in Florida
✅️ is currently active & recruiting
NCT04348747
NCI-Designated Cancer Centers
“I hear..” 😶 Source, please?
Thanks for reposting your free psychic predictions, but it sounds like you’re just spreading baseless rumors.
I thought you advised us to stick to “only hard facts” 😶 ..and we are much more interested in reliable sources & FACTS.
Examples of Reliable Sources:
☑️ Regulatory Agencies
☑️ U.S. DoD Grant Peer Reviewers
☑️ U.S. NIH Grant Peer Reviewers
☑️ Independently Peer-Reviewed Medical Journals
☑️ UCLA Jonsson Comprehensive Cancer Center
(NCI-Designated Cancer Center)
☑️ University of Pittsburgh Hillman Cancer Center
(NCI-Designated Cancer Center)
☑️ Roswell Park Comprehensive Cancer Institute
(NCI-Designated Cancer Center)
“Later this fall,” we want to see further updates & interim data on clinical trials. PII is a key stage for combo studies. New or expanded trials may soon be underway depending on funding & new partnerships or expansion of existing collaborations…
For example, we’re all interested in factual developments related to this PII Combo Trial at Roswell Park —
✅️ recently updated on clinicaltrials.gov
✅️ recently published/promoted at ASCO
✅️ recently expanded in scope
✅️ supported by a competitive peer-reviewed grant awarded by the U.S. DoD
✅️ includes Merck’s pembrolizumab
✅️ has a trial site at Moffitt in Florida
✅️ is currently active & recruiting
NCT04348747
NCI-Designated Cancer Centers
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
